Germany- based drugs maker Merck’s biotech division is reportedly about to set up an incubator in Israel, operated by its research facility, InterLab. Merck Serono will invest €10m ($14m) in the venture over seven years and provide a further €3m over the next three years for start-up companies in high tech and life sciences, news provider Globes said.

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?